Clinical Trials Browser

Phase 2 × INDUSTRY × Dexlansoprazole × Clear all

NCT02162758 2017-05-11

Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation

Phase 2 Terminated

6 enrolled 19 charts

Gastrointestinal

Barrett Esophagus